A comparative study of freezing single cells and spheroids: Towards a new model system for optimizing freezing protocols for cryobanking of human tumors

Fraunhofer Institut für Biomedizinische Technik, Ensheimer Strasse 48, 66386 St. Ingbert, Germany.
Cryobiology (Impact Factor: 1.59). 04/2009; 58(2):119-27. DOI: 10.1016/j.cryobiol.2008.11.005
Source: PubMed

ABSTRACT Cryopreservation of human tumour cells and tissue is a valuable tool for retrospective analysis and for the transport and handling of biopsy material. Tumour tissue consists of different cell types, which have different optimal freezing conditions, and extracellular matrix. A well-defined and authentic model system is required for developing new freezing protocols and media. This work describes the use of L929 and PC-3 spheroids as new model systems for freezing human tumours. Cell suspension and spheroids were frozen in different vessels (1 ml cryovials and a special, cryo-compatible 30 x 25 microl multi well plate) at slow rate (1 degrees C/min). Freezing media were combinations of culture or tumour transport medium (Liforlab) with the cryoprotective agents, Me(2)SO, trehalose and modified starch. We also present a new method of evaluating the viability of three dimensional multicellular systems to compare thawed spheroids objectively. Best viability (70%) of L929 spheroids occurred with a combination of Liforlab and starch hydrolysis product. The best cryopreservation results for spheroids were found with extracellular cryoprotectants, while optimum viability of single cells was achieved with Me(2)SO.

Download full-text


Available from: Alisa Katsen-Globa, Jan 20, 2015
36 Reads
  • Source
    • "Cell culture media were obtained from Gibco (Invitrogen, Darmstadt, Germany). Spheroids were produced using hanging droplet or free spheroid technique as described elsewhere [34]. Rin-m cells and Langerhans’ islets were stained using fluorescein diacetate (FDA) and ethidium bromide [34] for viability and membrane integrity assessment. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The technique of immunoisolated transplantation has seen in the last twenty years improvements in biocompatibility, long term stability and methods for avoidance of fibrosis in alginate capsules. However, two major problems are not yet solved: living cellular material that is not centered in the capsule is not properly protected from the hosts' immune system and the total transplant volume needs to be reduced. To solve these problems, we present a method for applying fully biocompatible alginate multilayers to a barium-alginate core without the use of polycations. We report on the factors that influence layer formation and stability and can therefore provide data for full adjustability of the additional layer. Although known for yeast and plant cells, this technique has not previously been demonstrated with mammalian cells or ultra-high viscous alginates. Viability of murine insulinoma cells was investigated by live-dead staining and live cell imaging, for murine Langerhans' islets viability and insulin secretion have been measured. No hampering effects of the second alginate layer were found. This multi-layer technique therefore has great potential for clinical and in vitro use and is likely to be central in alginate matrix based immunoisolated cell therapy.
    PLoS ONE 09/2013; 8(9):e73498. DOI:10.1371/journal.pone.0073498 · 3.23 Impact Factor
  • Source
    • "The intensity and rate of accumulation of the fluorescent product of FDA hydrolysis within the cells reflect both the enzymatic activity required for the hydrolysis and the integrity of the cell membrane necessary for the retention of the product. As a rule, the FDA staining is used for post-thawing estimation of cell vitality, since in the cells with damaged membranes, the accumulation of hydrolyzed fluorescein does not take place and the intracellular fluorescent signal is not observed [21,22]. Figure 5 presents a representative FDA staining image of U937 cells exposed to the freezing - thawing cycle in the i3C, at 3 hours after thawing. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The cryopreservation and thawing processes are known to induce many deleterious effects in cells and might be detrimental to several cell types. There is an inherent variability in cellular responses among cell types and within individual cells of a given population with regard to their ability to endure the freezing and thawing process. The aim of this study was to evaluate the fate of cryopreserved cells within an optical cryo apparatus, the individual-cell-based cryo-chip (i3C), by monitoring several basic cellular functional activities at the resolution of individual cells. In the present study, U937 cells underwent the freezing and thawing cycle in the i3C device. Then a panel of vital tests was performed, including the number of dead cells (PI staining), apoptotic rate (Annexin V staining), mitochondrial membrane potential (TMRM staining), cytoplasm membrane integrity and intracellular metabolism (FDA staining), as well as post-thawing cell proliferation assays. Cells that underwent the freezing - thawing cycle in i3C devices exhibited the same functional activity as control cells. Moreover, the combination of the multi-parametric analysis at a single cell resolution and the optical and biological features of the device enable an accurate determination of the functional status of individual cells and subsequent retrieval and utilization of the most valuable cells. The means and methodologies described here enable the freezing and thawing of spatially identifiable cells, as well as the efficient detection of viable, specific, highly biologically active cells for future applications.
    BMC Cell Biology 10/2010; 11(1):83. DOI:10.1186/1471-2121-11-83 · 2.34 Impact Factor
  • Source
    • "In order to determine plasma membrane integrity for the cell viability assay, cells were double-stained with PI and FDA. A mixture of FDA (final concentration 1.2 μM) and PI (final concentration 2.5 μg/ml) was added to U937 cells loaded into the i3C, for 5 minutes in the dark, at RT (the method is similar to that reported by Ehrhart et al. 2009 [33]). The cells were then imaged using fluorescence cubes for fluorescein and PI. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cryopreservation is the only widely applicable method of storing vital cells for nearly unlimited periods of time. Successful cryopreservation is essential for reproductive medicine, stem cell research, cord blood storage and related biomedical areas. The methods currently used to retrieve a specific cell or a group of individual cells with specific biological properties after cryopreservation are quite complicated and inefficient. The present study suggests a new approach in cryopreservation, utilizing the Individual Cell-based Cryo-Chip (i3C). The i3C is made of materials having appropriate durability for cryopreservation conditions. The core of this approach is an array of picowells, each picowell designed to maintain an individual cell during the severe conditions of the freezing--thawing cycle and accompanying treatments. More than 97% of cells were found to retain their position in the picowells throughout the entire freezing--thawing cycle and medium exchange. Thus the comparison between pre-freezing and post-thawing data can be achieved at an individual cell resolution. The intactness of cells undergoing slow freezing and thawing, while residing in the i3C, was found to be similar to that obtained with micro-vials. However, in a fast freezing protocol, the i3C was found to be far superior. The results of the present study offer new opportunities for cryopreservation. Using the present methodology, the cryopreservation of individual identifiable cells, and their observation and retrieval, at an individual cell resolution become possible for the first time. This approach facilitates the correlation between cell characteristics before and after the freezing--thawing cycle. Thus, it is expected to significantly enhance current cryopreservation procedures for successful regenerative and reproductive medicine.
    BMC Cell Biology 07/2010; 11:54. DOI:10.1186/1471-2121-11-54 · 2.34 Impact Factor
Show more